TheJobsMapOxurion jobs and careers
Leuven, Flanders, Belgium
About Oxurion
Oxurion (Euronext Brussels: OXUR - formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. The company has built a diverse portfolio of disease-modifying therapies, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide.
- Founded
- 1991
- Employees
- 125
- Total funding
- $194.2M
- Headquarters
- Leuven
Leadership
The top of Oxurion's org chart, with how many people report into each leader.
Philippe B.
Chief Scientific Officer
5 reports
Kathleen Paisley
Chief Legal Officer & General Counsel
2 reports
Andy De Deene
Chief Development Officer
1 report
Grace Chang
Chief Medical Officer
1 report
Linda Knott
Assistant To US Corporate Team
An Huysmans
Finance Director And Corporate Controller
Alfred Aronson
Director Human Resources
Tjing-Tjing Hu
Scientist Ophthalmology
François le Floch
Scientist, Downstream Process Expert
Michaël Porcu
Group Leader In vitro Biology
Tine Van Bergen
Senior Scientist
Astrid de Vriese
Principal Research Associate
Stijn Lagaert
IP Consultant
Samuel Darcheville
Part-time Seconded Corporate Legal Counsel
Eva Padgett
Business Analyst
Board
David Guyer
Non-Executive, Independent Director
Baron Philippe Vlerick
Non-Executive, Independent Director
Adrienne Graves
Non-Executive, Independent Director
Jobs at Oxurion
No open positions right now. Explore more companies on TheJobsMap.